Grünenthal Company Profile

08:25 EDT 4th September 2015 | BioPortfolio

Grünenthal è una società farmaceutica indipendente, basata sulla ricerca con operazioni internazionali. E' sempre stata una società a capitale privato fin dalla sua fondazione nel 1946. I prodotti Grünenthal sono commercializzati in oltre 80 Paesi e il numero delle filiali è in continua crescita. Grünenthal occupa circa 4.800 persone a livello mondiale, persone che hanno dato un grande contributo per il successo della Società.L'ulteriore consolidamento attraverso una ricerca innovativa è una parte integrante della politica della nostra Società. L'ambizione di Grünenthal è quella di essere una società leader nella Ricerca e Sviluppo in campi selezionati: l'area dolore è la nostra competenza core.

Location

Via Correggio, 43
Milano
20149
Italy

Contact

Phone: 39-02-43051
Fax: 39-02-430555
Email: dg@grunenthal.com


News Articles [7 Associated News Articles listed on BioPortfolio]

Therametrics und Grünenthal vereinbaren Zusammenarbeit

Stans (awp) - Das Biotechnologieunternehmen Therametrics und das deutsche Pharmaunternehmen Grünenthal GmbH vereinbaren eine Zusammenarbeit. Demnach darf Grünenthal die Therametrics-Software DRR 2.....

AYOXXA and Grünenthal validate protein multiplexing technology in inflammation study

AYOXXA Biosystems and Grünenthal have been using AYOXXA's protein multiplexing technology platform to analyse an inflammation marker at very low concentrations released from human cells following tre...

AYOXXA and Grünenthal Completed Research Collaboration

Successful validation of protein multiplexing technology platform        Cologne, Germany, June 24, 2015 / B3C newswire / -- AYOXXA Biosystems and Grünenthal, a ...

EFIC-Grünenthal Grant Honours 7 Young Scientists for Their Groundbreaking Pain Research Ideas

BRUSSELS and AACHEN, Germany, June 12, 2015 /PRNewswire/ -- - The continuing Success Story on Research in improving pain patients' lives Pain is a common condition, which affects one in five adult c...

Grünenthal, Boston Children's Hospital and Proteus S.A. Announce a Partnership and Development Program for Neosaxitoxin

AACHEN, Germany, SANTIAGO DE CHILE, Chile and BOSTON, June 12, 2015 /PRNewswire/ --   Partnership program with Proteus S.A. (Chile) and Boston Children's Hospital (USA)  Grünenthal'...

Results of Pain Research Projects Raise Aspiration for Advanced Pain Treatment

VIENNA, September 3, 2015 /PRNewswire/ -- Novel ideas for potential improvement of pain management  High need for translation of findings into practice for improved patients' quality of life...

Austin Pain Associates Seeks Patients With Complex Regional Pain Syndrome for Clinical Trial of Infusion Therapy Using Neridronic Acid

AUSTIN, TX -- (Marketwired) -- 08/03/15 -- Austin Pain Associates (APA), the leader in pain management in central Texas, is pleased to announce that it is participating in a clinical trial to study t...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [3 Associated Companies listed on BioPortfolio]

Grünenthal

Grünenthal è una società farmaceutica indipendente, basata sulla ricerca con operazioni internazionali. E' sempre stata una società a capitale privato fin dalla sua fondazione nel 1946. I prodotti...

Gr?nenthal

Grünenthal GmbH

Nil

More Information about "Grünenthal" on BioPortfolio

We have published hundreds of Grünenthal news stories on BioPortfolio along with dozens of Grünenthal Clinical Trials and PubMed Articles about Grünenthal for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Grünenthal Companies in our database. You can also find out about relevant Grünenthal Drugs and Medications on this site too.


Advertisement
 
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record